The Prevalence and Antimicrobial Susceptibility of Methicillin-Resistant Staphylococcus aureus Before and After the COVID-19 Pandemic in a Tertiary Saudi Hospital.

covid-19 makkah mrsa mssa s. aureus

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2024
Historique:
accepted: 24 02 2024
medline: 26 3 2024
pubmed: 26 3 2024
entrez: 26 3 2024
Statut: epublish

Résumé

Methicillin-resistant The study aimed to evaluate the prevalence of A total of 2128 and 1515 laboratory (lab) samples were collected during the years 2019 and 2020, respectively. From these samples, the prevalence of The present study shows that the lab prevalence of all S. It was concluded that the prevalence rates of MRSA have not increased in 2020 when compared to 2019. Vancomycin, linezolid, trimethoprim-sulfamethoxazole, and doxycycline remain susceptible to the positive collected MRSA strains. There was no significant difference between the prevalence and antimicrobial resistance rates of MRSA between 2019 and 2020. Continued research efforts are needed to address this persistent public health threat. Strategies to control the spread of MRSA should include early detection of MRSA and surveillance, even during pandemics.

Sections du résumé

BACKGROUND BACKGROUND
Methicillin-resistant
AIMS OBJECTIVE
The study aimed to evaluate the prevalence of
METHODOLOGY METHODS
A total of 2128 and 1515 laboratory (lab) samples were collected during the years 2019 and 2020, respectively. From these samples, the prevalence of
RESULTS RESULTS
The present study shows that the lab prevalence of all S.
CONCLUSION CONCLUSIONS
It was concluded that the prevalence rates of MRSA have not increased in 2020 when compared to 2019. Vancomycin, linezolid, trimethoprim-sulfamethoxazole, and doxycycline remain susceptible to the positive collected MRSA strains. There was no significant difference between the prevalence and antimicrobial resistance rates of MRSA between 2019 and 2020. Continued research efforts are needed to address this persistent public health threat. Strategies to control the spread of MRSA should include early detection of MRSA and surveillance, even during pandemics.

Identifiants

pubmed: 38529437
doi: 10.7759/cureus.54809
pmc: PMC10962010
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e54809

Informations de copyright

Copyright © 2024, Ahmed et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Omar B Ahmed (OB)

Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.

Fayez S Bahwerth (FS)

Laboratory, King Faisal Hospital, Makkah, SAU.

Radi Alsafi (R)

Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, SAU.

Eman A Elsebaei (EA)

Medical Microbiology, Egypt Healthcare Authority, Cairo, EGY.

Gamal T Ebid (GT)

Laboratory Medicine, Security Forces Hospital, Makkah, Makkah, SAU.
National Cancer Institute, Cairo University, Cairo, EGY.

Abdulrhaman Theyab (A)

Department of Laboratory and Blood Bank, Security Forces Hospital, Mecca, Makkah, SAU.
Collage of Medicine, Al-Faisal University, Riyadh, SAU.

Hamza Assaggaf (H)

Laboratory Medicine/Public Health, Umm Al-Qura University, Makkah, SAU.

Classifications MeSH